Valuation: LeMaitre Vascular, Inc.

Market Cap 1.85B 1.64B 1.52B 1.39B 2.61B 175B 2.66B 18.3B 7.18B 91.54B 6.94B 6.79B 292B P/E 2026 *
28.1x
P/E 2027 * 25.4x
Enterprise Value 1.61B 1.43B 1.32B 1.21B 2.27B 153B 2.31B 15.92B 6.24B 79.63B 6.03B 5.91B 254B EV / Sales 2026 *
5.81x
EV / Sales 2027 * 5.11x
Free-Float
87.26%
Yield 2026 *
1.24%
Yield 2027 * 1.39%
1 day-2.81%
1 week+0.16%
Current month-2.14%
1 month+0.55%
3 months-21.56%
6 months-27.61%
Current year-0.35%
1 week 80.03
Extreme 80.0299
84.66
1 month 78.22
Extreme 78.22
84.66
Current year 78.22
Extreme 78.22
118.01
1 year 78.22
Extreme 78.22
118.01
3 years 44.27
Extreme 44.27
118.01
5 years 38.32
Extreme 38.32
118.01
10 years 18.55
Extreme 18.55
118.01
Manager TitleAgeSince
Chief Executive Officer 61 01/06/1992
Director of Finance/CFO 51 10/03/2025
Director of Finance/CFO 62 01/01/2000
Director TitleAgeSince
Director/Board Member 68 01/01/2003
Chairman 61 01/01/2004
Director/Board Member 61 24/10/2016
Date Insider Type Main position Quantity % Market Cap. Importance
3/9/26 Free

Chairperson

24 0.0001%
3/9/26 Free

Director

6 0.0000%
3/9/26 Free

Chief Operating Officer

14 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-2.81%+0.16%-6.93%+68.62% 1.85B
-0.93%+4.86%+28.54%+41.24% 255B
-1.06%+4.20%+8.59%+8.83% 161B
-0.27%+0.65%-1.82%+55.64% 151B
+0.57%+3.88%-54.60%-11.40% 64.33B
+1.47%+5.90%-12.94%-13.05% 51.9B
-1.70%+1.63%+19.20%+21.51% 49.92B
-0.85%+4.81%+6.02%+46.42% 50.25B
-1.47%+1.42%+22.59%+55.13% 48.77B
-1.62%+0.73%+30.48%+71.24% 42.93B
Average -0.87%+3.30%+3.91%+34.42% 87.68B
Weighted average by Cap. -0.70%+4.12%+8.97%+32.16%

Financials

2026 *2027 *
Net sales 277M 246M 228M 207M 391M 26.25B 397M 2.74B 1.07B 13.7B 1.04B 1.02B 43.66B 303M 269M 250M 227M 428M 28.75B 435M 3B 1.18B 15B 1.14B 1.11B 47.83B
Net income 66.71M 59.3M 54.96M 50.01M 94.37M 6.33B 95.88M 661M 259M 3.3B 250M 245M 10.53B 74.29M 66.04M 61.21M 55.69M 105M 7.05B 107M 736M 288M 3.68B 279M 273M 11.73B
Net Debt -240M -214M -198M -180M -340M -22.83B -346M -2.38B -934M -11.91B -903M -883M -37.97B -300M -267M -247M -225M -425M -28.51B -432M -2.97B -1.17B -14.88B -1.13B -1.1B -47.43B
Projected Income Statement - Annual - LeMaitre Vascular, Inc.
Logo LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. It develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser degree, other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which are used in open vascular surgery and dialysis access. It offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold globally in the United States, Europe, Canada and Asia Pacific.
Employees
651
Date Price Change Volume
16/10/26 USD 80.82 -2.81% 311,556
15/10/26 USD 83.16 +0.65% 297,900
14/10/26 USD 82.62 +1.31% 316,034
13/10/26 USD 81.55 -1.64% 247,757
12/10/26 USD 82.91 +2.75% 257,857
Trader
Investor
Global
Quality
ESG MSCI
CCC
MarketScreener Ratings - LeMaitre Vascular, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
80.82USD
Average target price
107.00USD
Spread / Average Target
+32.39%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LeMaitre Vascular, Inc.
  1. Stock Market
  2. Stocks
  3. LMAT Stock